Changing the definition of sequencing.
10X Genomics is changing the definition of sequencing by providing an innovative genomics platform that dramatically upgrades the capabilities of existing short read sequencers. The company does this through a combination of elegant microfluidics, chemistry, and bioinformatics. With the GemCode Platform, researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows.
- Location: Pleasanton, CA
- Paladin Initial Investment Date: November 2011